<DOC>
	<DOCNO>NCT00004264</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Chemoprotective drug amifostine may protect normal cell side effect chemotherapy . PURPOSE : Phase I/II trial study effectiveness combine docetaxel , cisplatin , amifostine treat patient advance non-small cell lung cancer surgically remove .</brief_summary>
	<brief_title>Docetaxel , Cisplatin , Amifostine Treating Patients With Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose docetaxel combine amifostine high dose cisplatin patient advance non-small cell lung cancer . II . Determine response rate survival patient treat regimen . III . Determine tolerability regimen patient . OUTLINE : This dose escalation , multicenter study docetaxel . Patients receive amifostine IV 15 minute , immediately follow docetaxel IV 1 hour , follow hour 2 amifostine , immediately follow high dose cisplatin IV 30 minute . Treatment repeat every 4 week absence disease progression unacceptable toxicity . Cohorts patient receive escalate dos docetaxel maximum tolerate dose determine . PROJECTED ACCRUAL : A total 15-30 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove unresectable advanced nonsmall cell lung cancer Stable CNS metastases allow PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 0 1 Life expectancy : Not specify Hematopoietic : WBC least 3,500/mm3 Absolute neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : AST great 2.5 time upper limit normal ( ULN ) AND alkaline phosphatase great ULN OR AST great ULN AND alkaline phosphatase great 4 time ULN Renal : Creatinine clearance least 60 mL/min Other : Not pregnant Fertile patient must use effective contraception No peripheral neuropathy bad grade 1 PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Any type number prior chemotherapy regimen allow recover Greater 3 month since prior cisplatin recover Endocrine therapy : Prior endocrine therapy allow recovered Radiotherapy : Prior radiotherapy allow recover Surgery : Prior surgery allow recover Other : No concurrent medication could cause renal injury</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2000</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>drug/agent toxicity tissue/organ</keyword>
</DOC>